Soc. Generale Knock-Out MRK/ DE000SU4H309 /
17/05/2024 21:43:55 | Chg.-0.01 | Bid22:00:47 | Ask22:00:47 | Underlying | Strike price | Expiration date | Option type |
---|---|---|---|---|---|---|---|
2.16EUR | -0.46% | - Bid Size: - |
- Ask Size: - |
Merck and Co Inc | 107.2792 USD | 31/12/2078 | Call |
GlobeNewswire
16/05
Vaccinex Reports First Quarter 2024 Financial Results and Provides Corporate Update
GlobeNewswire
14/05
IO Biotech Reports First Quarter 2024 Financial Results and Provides Business Highlights
GlobeNewswire
08/05
C4 Therapeutics Reports First Quarter 2024 Financial Results and Recent Business Highlights
GlobeNewswire
24/04
IO Biotech Announces Abstract Accepted for Presentation at the 2024 American Society of Clinical Onc...
GlobeNewswire
15/04
IO Biotech Expands Senior Leadership Team to Progress Commercialization Readiness
GlobeNewswire
09/04
IO Biotech Presents New Data at AACR 2024 Further Supporting Dual Mechanism of Action of Lead Cancer...
GlobeNewswire
18/03
Aspira Women’s Health Expands Senior Leadership Team with the Addition of Sandra Milligan, M.D., J.D...
GlobeNewswire
15/03
American Kidney Fund Announces 2024 Class of Corporate Members Providing Support in the Fight Agains...
GlobeNewswire
06/03
IO Biotech Announces Acceptance of Abstract to be Presented at the 2024 American Association for Can...
GlobeNewswire
07/02
Alleo Labs Announces Publication on the Use of Artificial Intelligence in Neuroscience Drug Discover...
GlobeNewswire
09/01
C4 Therapeutics Announces 2024 Priorities and Extended Cash Runway to Advance Portfolio of Targeted ...
GlobeNewswire
21/12/2023
IO Biotech Announces First Patient Dosed in Phase 2 Neoadjuvant/Adjuvant Solid Tumor Basket Trial